Ticker
CSCIFCompany Name
COSCIENS BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -18.2M | -192.8% | $ 9.44M |
3/31/2025 | $ -15.26M | -168.94% | $ 9.03M |
12/31/2024 | $ -15.73M | -164.07% | $ 9.59M |
9/30/2024 | $ -19.14M | -441.63% | $ 4.33M |
6/30/2024 | $ -14.62M | -593.06% | $ 2.46M |
3/31/2024 | $ -17.37M | -731.63% | $ 2.37M |
12/31/2023 | $ -17.14M | -380.99% | $ 4.5M |
9/30/2023 | $ -15.13M | -220.49% | $ 6.86M |
6/30/2023 | $ -15.69M | -179.96% | $ 8.72M |
3/31/2023 | $ -16.29M | -260.55% | $ 6.25M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for COSCIENS BIOPHARMA INC is calculated as follows: FCF [ $ -9.6M ] / Revenues [ $ 1.3M ]
(=) FCF % [ -735.81% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.88% |
median | 7.4% |
std | 19.48% |